Few X-ray and PUVA treatments accelerate photocarcinogenesis in hairless mice
- PMID: 34559384
- DOI: 10.1007/s43630-021-00105-y
Few X-ray and PUVA treatments accelerate photocarcinogenesis in hairless mice
Abstract
PUVA is a treatment that combines oral methoxypsoralen (8-MOP) with ultraviolet radiation A (UVA). It is used for severe psoriasis and the early stages of T-cell lymphoma. X-rays are an effective treatment for skin cancers. Both treatments are in higher doses used to treat skin malignancies and simultaneously increase the risk of keratinocyte cancer. The main objective of this study was to test whether a few PUVA or X-ray treatments could delay the development of ultraviolet radiation (UVR)-induced skin tumors in a well-established hairless mouse model. Three groups of immunocompetent mice (total, N = 75) were included in the study. All groups were UVR-exposed during the study period. In addition, one group was treated with PUVA and another group was treated with X-rays at days 45, 52, 90 and 97. A control group was treated with UVR only. We recorded when the first, second and third skin tumors were induced in each mouse. Skin tumors developed significantly earlier in both the PUVA and X-ray groups (median, 188 days) than in the control mice (median, 215 days; p < 0.001). Therefore, a few X-ray and PUVA treatments both significantly accelerated the development of skin tumors in hairless mice, compared to UVR controls. Neither treatment showed a delay of UVR-induced skin tumors and caution should be exercised before applying these treatments to sun-damaged skin.
Keywords: 8-MOP; Hairless mice; PUVA; Prophylactic treatment; Radiation therapy; Skin tumors; Ultraviolet radiation; X-ray.
© 2021. The Author(s), under exclusive licence to European Photochemistry Association, European Society for Photobiology.
Similar articles
-
Photocarcinogenesis and toxicity of benzoyl peroxide in hairless mice after simulated solar radiation.Exp Dermatol. 2010 Apr;19(4):381-6. doi: 10.1111/j.1600-0625.2009.00927.x. Epub 2009 Aug 23. Exp Dermatol. 2010. PMID: 19703226
-
Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice.Exp Dermatol. 2010 Nov;19(11):973-9. doi: 10.1111/j.1600-0625.2009.01034.x. Exp Dermatol. 2010. PMID: 20113348
-
X-rays and photocarcinogenesis in hairless mice.Arch Dermatol Res. 2013 Aug;305(6):529-33. doi: 10.1007/s00403-013-1344-7. Epub 2013 Mar 31. Arch Dermatol Res. 2013. PMID: 23543228
-
Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.J Pediatr. 1996 Dec;129(6):915-7. doi: 10.1016/s0022-3476(96)70039-2. J Pediatr. 1996. PMID: 8969737 Review.
-
Cumulative effects of ultraviolet radiation on the skin: cancer and photoaging.Semin Dermatol. 1990 Mar;9(1):25-31. Semin Dermatol. 1990. PMID: 2203440 Review.
References
-
- Lindelöf, B., & Eklund, G. (1986). Incidence of malignant skin tumors in 14,140 patients after Grenz-ray treatment for benign skin disorders. Archives of Dermatology, 122(12), 1391–1395. https://doi.org/10.1001/archderm.1986.01660240055015 - DOI - PubMed
-
- Karagas, M. R., et al. (1996). Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. Journal of the National Cancer Institute, 88(24), 1848–1853. https://doi.org/10.1093/jnci/88.24.1848 - DOI - PubMed
-
- Wolfe, C. M., Green, W. H., Hatfield, H. K., Shakar, T. J., Baniahmad, O., & Cognetta, A. B. (2012). Multiple secondary cutaneous tumours following electron beam radiotherapy for cutaneous malignancies of the scalp. Australasian Journal of Dermatology, 53(3), 233–238. https://doi.org/10.1111/j.1440-0960.2012.00917.x - DOI
-
- Hulyalkar, R., Rakkhit, T., & Garcia-Zuazaga, J. (2011). The role of radiation therapy in the management of skin cancers. Dermatologic Clinics, 29(2), 287–296. https://doi.org/10.1016/j.det.2011.01.004 - DOI - PubMed
-
- Warner, J. A., & Cruz, P. D. J. (2008). Grenz ray therapy in the new millennium: Still a valid treatment option? Dermatitis: Contact Atopic, Occupational Drug, 19(2), 73–80. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical